Mochi Health review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, Mochi Health prices out at $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership. That ranks #4 of 17 priced compounded programs — $63 a month above the field's floor (NexLife at $215). Semaglutide runs $178 a month all-in. (#6 of 19 on our semaglutide basis)

What the fine print says

The number to hold onto is the all-in figure: the $79 monthly membership is mandatory, recurs, and belongs in any comparison — advertised medication-only prices here understate the bill. The medication price is not the price you pay: a monthly membership is mandatory, so the advertised medication figure understates the billed total unless you add the $79 membership.

Pharmacy & transparency

Price evidence: Source-verified, last verified 2026-08-05. Pharmacy disclosure is a strength: company-owned compounding facility — owned facility.

The dose ladder, priced rung by rung

Walk Mochi Health's ladder and the price never moves: every rung from 2.5 to 15 mg bills the same $278, which turns titration from a budgeting exercise into a clinical one. The practical consequences compound over a treatment course: the standard four-month climb to 10 mg costs exactly $1,112 (four flat months, no arithmetic), a post-plateau escalation from 10 to 12.5 mg is clinically free, and holding a dose an extra month for tolerability — the standard side-effect play — changes nothing on the bill. Against dose-scaled competitors whose entry figures climb 40–75% by maintenance, and against Zepbound's $299→$449 steps, a flat ladder means the advertised number is the number you keep paying.

What the first year actually bills

The annual number — the honest one — is $3,336 for year one on Mochi Health's standing plan: twelve identical charges of $278, titration included, because the flat structure makes month one and month twelve the same line item. No prepaid tier is published, so the standing rate is the only rate — simpler, and fully flexible. Benchmarked to the verified floor, the year costs $756 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

Because this class works while taken, the two-year number deserves the spotlight: Mochi Health at standing rates bills $6,672 across 24 months. The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

Mochi Health prices semaglutide at $178/month all-in at the standing rate, ranking #6 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. Plan detail worth reading before checkout: $99 medication plus a mandatory $79/mo membership ($39 for the first month), the same price at every dose, with unlimited physician and dietitian access included. The in-house premium for stepping up to tirzepatide is $100/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, Mochi Health's $278 all-in rate ranks #4 of 17: $63/month above the NexLife floor; one rung cheaper sits IVIM Health at $278 (a $0/mo gap); one rung pricier is Found at $289. Against the FDA-approved benchmark, the same year costs $2,052 less than Zepbound's $449 maintenance tier — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $278 — same as every later month on the flat plan. The 10 mg maintainer. Settled at maintenance, the run-rate is $278/month, $3,336/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. No prepaid tier exists here; the committed-money crowd should compare Found's $169 and NexLife's $186 twelve-month effectives instead.

Nearest alternatives at this price point

Price-band neighbors worth a look before deciding: Mochi Health at $278 (flat at every dose, named pharmacy); Found at $289 (flat at every dose, no membership, prepaid to $169); ShedRx at $289 (no membership) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Mochi Health publishes availability of: most states. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) confirmation that fulfillment still runs through its named network (company-owned compounding facility) for your state; (3) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit Mochi Health — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

Mochi Health sits mid-pack on tirzepatide price. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.